Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Oct 13, 2026

ERAS — Erasca, Inc. Dilution Risk Tracker

Track ERAS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ERAS — Get alerts when the score changes →

As of October 13, 2026, Erasca, Inc. (ERAS) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Erasca, Inc. has a market capitalization of $5.41B, 349.76M shares outstanding, 226 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $200.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
27
💰 Cash Runway
65
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 16%
💰 Capital Raise model 33%
• Under 12 months cash (10mo)
• Active ATM program with $200M remaining capacity
🔔 Track ERAS — Get forecast alerts →

Market Data

Market Cap$5.41B
Shares Outstanding349.76M
Float207.89M
Cash$96.53M
Debt$45.95M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore36/100DilutionWatch score record
Shares Outstanding349.76MVerified float table or market cache
Public Float207.89MVerified float table or market cache
Market Cap$5.41BMarket data cache
Cash Runway9.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$200.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 36.7% shares (2026Q1 vs prior)
226 institutional holders · 312.71M shares
#1 Frazier Life Sciences Management, L.P. 24.68M shares
#2 Vivo Capital, LLC 24.30M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 22.50M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest35.34M
Days to Cover6.9
% of Float17.0%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-03-23
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-06
4 INSIDER TRANSACTION 2026-01-30
4 INSIDER TRANSACTION 2026-01-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ERAS Dilution Snapshot

Erasca, Inc. (ERAS) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ERAS's DilutionScore is currently 36/100 (Medium risk), with 3 score changes tracked over 89 days. The score deteriorated from 39/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202636/100MEDIUM4 days
Aug 22 – Oct 09, 202639/100MEDIUM49 days
Aug 14 – Aug 21, 202637/100MEDIUM7 days
Jul 16 – Aug 13, 202640/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ERAS shares outstanding have increased 0.5% from 309.59M (Mar 2026) to 310.98M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 19, 2026310.98M207.89M▼ 8.01%
May 14, 2026310.98M225.99M▲ 0.06%
May 10, 2026310.97M225.85M▲ 0.02%
May 03, 2026310.97M225.81M▲ 0.73%
Mar 17, 2026309.59M224.17M▲ 0.15%
Mar 14, 2026309.59M223.83M▲ 9.55%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ERAS Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ERAS files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ERAS — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ERAS
ERAS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.